Adenoviral gene transfer of fortilin attenuates neointima formation through suppression of vascular smooth muscle cell proliferation and migration.
BACKGROUND
Fortilin, a recently characterized nuclear antiapoptotic factor structurally distinct from inhibitor of apoptosis proteins (IAPs) and Bcl-2 family member proteins, has been suggested to be involved in cell survival and regulation of apoptosis within the cardiovascular system. In this continued investigation, we characterized the influence of adenovirus-mediated fortilin (Ad-fortilin) gene delivery on vascular remodeling after experimental angioplasty.


RESULTS
Vessel wall expression of Ad-fortilin or adenoviral luciferase (Ad-luc) was demonstrated 72 hours and 14 days after rat carotid artery (CA) balloon angioplasty. Morphometric analyses 14 days after injury revealed significantly diminished neointima development in the Ad-fortilin-treated CAs compared with Ad-luc or PBS controls, with no changes in medial wall morphometry observed between the 3 groups. The Ad-fortilin-treated CAs demonstrated a 50% reduction in medial wall proliferating cell nuclear antigen (PCNA) labeling after 72 hours, with significantly reduced neointimal and medial wall PCNA labeling and cell counts after 14 days. Terminal dUTP nick-end labeling results and morphological changes characteristic of programmed cell death suggest a trend toward reduced apoptosis in the fortilin-transfected balloon-injured vessels compared with Ad-luc injured controls. Temporal analysis of human aorta smooth muscle cell (SMC) proliferation demonstrated a marked time-dependent inhibition in Ad-fortilin treated SMCs without the influence of elevated apoptosis. Thymidine incorporation was significantly inhibited in the Ad-fortilin-treated cells compared with Ad-luc controls. Ad-fortilin transfected SMCs also demonstrated significantly decreased migration compared with Ad-luc controls.


CONCLUSIONS
These cumulative results suggest that the novel antiapoptotic protein fortilin may play important redundant pathophysiological roles in modulating the vascular response to experimental angioplasty through suppression of SMC proliferation and migration concomitant with reduction of vessel wall apoptosis.
Tulis
David A
DA
Department of Medicine, Baylor College of Medicine, Houston, Tex 77030, USA. dtulis@bcm.tmc.edu
Mnjoyan
Zakar H
ZH
Schiesser
Rachel L
RL
Shelat
Harnath S
HS
Evans
Alida J
AJ
Zoldhelyi
Pierre
P
Fujise
Ken
K
D000256:Adenoviridae / Q000235:genetics*; D000800:Angioplasty, Balloon / Q000009:adverse effects; D000818:Animals; D001157:Arterial Occlusive Diseases / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D014408:Biomarkers, Tumor; D016893:Carotid Stenosis / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D002455:Cell Division; D002465:Cell Movement; D002478:Cells, Cultured; D015316:Genetic Therapy; D005822:Genetic Vectors; D007700:Kinetics; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000503:physiopathology*; D009363:Neoplasm Proteins; D009687:Nuclear Proteins / Q000235:genetics*; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D013936:Thymidine / Q000096:biosynthesis; D014162:Transfection; D000090324:Tumor Protein, Translationally-Controlled 1
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D018809:Proliferating Cell Nuclear Antigen; D000090324:Tumor Protein, Translationally-Controlled 1; D013936:Thymidine